Additionally, Kim et al. found that continuous supplementation of HFD rats with low doses of nobiletin over 16 weeks resulted in reduced plasma total cholesterol, apolipoprotein B (ApoB), and non-high-density lipoprotein levels, ultimately improving dyslipidemia (Kim et al., 2017). Here, APOB is linked to metabolic syndrome.